Sassenage, France

Séverine Collin

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Séverine Collin: Pioneering Advances in Microalgal Protein Production

Introduction: Séverine Collin, an inventive mind based in Sassenage, France, has made significant strides in biotechnological research. With a keen focus on the utilization of microalgae for protein production, his work contributes to advancements in the field of genetic engineering and agricultural applications.

Latest Patents: Séverine Collin holds one prominent patent titled "Chloroplast targeting peptide sequence derived from nannochloropsis phosphoribulokinase and methods for use." This innovative patent focuses on chloroplast targeting of nuclear-encoded proteins of interest within microalgae. The invention presents expression cassettes that integrate a nucleotide sequence encoding a chloroplast targeting peptide linked to a sequence encoding a protein of interest. This technology includes vectors that incorporate these expression cassettes, allowing microalgae to stably or transiently express desired proteins within their nuclear genomes. Furthermore, methods for the production of proteins of interest in microalgal chloroplasts and techniques for modulating chloroplast pathways are outlined in the patent.

Career Highlights: Currently, Séverine Collin is affiliated with Total Raffinage Chimie, a company known for its innovative approaches in the energy and chemical sectors. His role there enables him to leverage his expertise in biotechnology and contribute to practical applications of his research.

Collaborations: Throughout his career, Séverine has worked alongside notable colleagues, including Leonardo Magneschi and Eric Marechal. This collaborative environment fosters creativity and innovation, allowing for the exchange of ideas that further enhance their collective contributions to science and technology.

Conclusion: Séverine Collin exemplifies the spirit of innovation within the realm of biotechnological research. His patent on chloroplast targeting peptides signifies a valuable contribution to the field and showcases his dedication to advancing the utilization of microalgae for protein production. As he continues to collaborate with fellow innovators, the impact of his work is poised to resonate across the scientific community and industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…